pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
CNA-3103
Metastatic Colorectal Cancer
Carina Biotech Pty Ltd
0 catalysts
Phase 2
CNP-103
Type 1 Diabetes (Juvenile Diabetes)
Cour Pharmaceuticals Development Co Inc
0 catalysts
Phase 2
CNP-104
Primary Biliary Cholangitis (Primary Biliary Cirrhosis)
Cour Pharmaceuticals Development Co Inc
0 catalysts
Phase 2
CNP-106
Myasthenia Gravis
← prev
page 9 of 50
next →
131
Pain89
Neurology1
Cour Pharmaceuticals Development Co Inc
0 catalysts
Phase 2
CNS10-NPC
Amyotrophic Lateral Sclerosis
Cedars-Sinai Medical Center
0 catalysts
Phase 2
CNTX-6016
Diabetic Neuropathic Pain
Centrexion Therapeutics Corp
0 catalysts
Phase 2
COM-701
Endometrial Cancer
$CGENCOMPUGEN LTD
0 catalysts
Phase 2
COVID-19 (S Protein)
Coronavirus Disease 2019 (COVID-19)
$VXRTVaxart, Inc.
0 catalysts
Phase 2
COYA-302
Amyotrophic Lateral Sclerosis
$COYACoya Therapeutics, Inc.
0 catalysts
Phase 2
CPL-500036
Schizophrenia
Celon Pharma SA
0 catalysts
Phase 2
CR-001
Cervical Cancer
Crescent Biopharma Operating Co LLC
0 catalysts
Phase 2
CRN-09682
Breast Cancer
$CRNXCrinetics Pharmaceuticals, Inc.
0 catalysts
Phase 2
CRS-3123
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Methionine--tRNA ligase
Crestone Inc
0 catalysts
Phase 2
CS-0159
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Cascade Pharmaceuticals Inc
0 catalysts
Phase 2
CS-02
Type 2 Diabetes
Center Laboratories Inc
0 catalysts
Phase 2
CS-1103
Substance (Drug) Abuse
Clear Scientific Inc
0 catalysts
Phase 2
CSB-001
Neurotrophic Keratitis
Claris Biotherapeutics Inc
0 catalysts
Phase 2
CST-3056
Neurogenic Orthostatic Hypotension (nOH)
CuraSen Therapeutics Inc
0 catalysts
Phase 2
CT-071
Plasma Cell Neoplasm
CARsgen Therapeutics Holdings Ltd
0 catalysts
Phase 2
CT-101
Bone Fracture
$XAGELongevity Health Holdings, Inc.
0 catalysts
Phase 2
CT-868
Type 1 Diabetes (Juvenile Diabetes)
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
CTO-1681
Cytokine Release Syndrome (Cytokine Storm)
CytoAgents Inc
0 catalysts
Phase 2
CTx-001
Geographic Atrophy
B-cell lymphoma/leukemia 11A
Complement Therapeutics Ltd
0 catalysts
Phase 2
CTxPDE-6b
Retinitis Pigmentosa (Retinitis)
Coave Therapeutics
0 catalysts
Phase 2
CUE-101
Human Papillomavirus (HPV) Associated Cancer
$CUECue Biopharma, Inc.
0 catalysts
Phase 2
CX-001
Nevus
Calissa Therapeutics
0 catalysts
Phase 2
CX-1739
Central Sleep Apnea
Glutamate receptor ionotropic AMPA
EndeavourRx LLC
0 catalysts
Phase 2
CX-717
Attention Deficit Hyperactivity Disorder (ADHD)
EndeavourRx LLC
0 catalysts
Phase 2
CYP-001
Graft Versus Host Disease (GVHD)
Cynata Therapeutics Ltd
0 catalysts
Phase 2
CampETEC
Campylobacter Infections
$IMRNImmuron Ltd
0 catalysts